2016-07-26T04-37-20Z
Source: International Journal of Research in Medical Sciences
Subrata Halder, Bikram Kr. Saha, Debasis Sarkar, Srabani Ghosh.
Background: This study was done to know about the clinical biochemical as well as radiological profile of patients presented as generalized lymphadenopathy in a tertiary care centre and to know the different causes of generalized lymphadenopathy. Methods: 116 patients of generalized lymphadenopathy were included this study based on the inclusion and exclusion criteria. Detailed history, physical examination and relevant systemic examination including detailed examination of lympho-reticular system were done as per a structured proforma and necessary lab investigations were done for confirming diagnosis. Results: Among 116 patients of generalized lymphadenopathy 59.5% were non-malignant causes where 40.5% diagnosed as malignant causes. Among them tuberculosis consist of 39 (33.6%), NHL 18 (15.5%), reactive lymphadenopathy 16 (13.8%), CLL and HD 8 (6.9%) each, ALL 7 (6%), SLE 5(4.3%), Kikuchis disease 4 (3.4%), AML and RA 3 (2.6%) each and castlemans disease, phenytoin lymphadenopathy, metastatic lung and breast carcinoma 1 (0.9%) each. Cervical groups of lymph nodes were most commonly involved 86 patients (74.1%) followed by axillary groups 73 patients (62.9%). Lymph nodes size 1.5cm were due to malignant and non-malignant granulomatous cases. FNAC give definite diagnosis 80.9% malignant cases where 76.8% in non-malignant cases. HPE shown definite diagnosis in 100% cases both malignant and non-malignant diseases. Conclusions: Tuberculosis is most common cause of generalized lymphadenopathy followed by lymphoma. And reactive lymphadenitis is also an important consideration.
from Scope via xlomafota13 on Inoreader http://ift.tt/2ady6dL
via IFTTT
Τρίτη 26 Ιουλίου 2016
Etiological study of generalized lymphadenopathy in a tertiary care hospital
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.